Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks

Pediatrics

Volumn 118, Issue 5, 2006, Pages

  Walsh, Michele C ^a,d   Yao, Qing ^a   Horbar, Jeffrey D ^b   Carpenter, Joseph H ^b   Lee, Shoo K ^c   Ohlsson, Arne ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b VERMONT OXFORD NETWORK   (United States)

^c Canadian Neonatal Network Coordinating Centre   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bronchopulmonary dysplasia; Corticosteroids

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE;

ARTICLE; BIRTH WEIGHT; CHILD HOSPITALIZATION; COHORT ANALYSIS; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO; VERY LOW BIRTH WEIGHT; CLINICAL TRIAL; DRUG UTILIZATION; MULTICENTER STUDY; RETROSPECTIVE STUDY; STATISTICS;

ADRENAL CORTEX HORMONES; BRONCHOPULMONARY DYSPLASIA; DRUG UTILIZATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES;

EID: 33750945344     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0359     Document Type: Article

References (16)

1. Cummings JJ, D'Eugionio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505-1510
2. O'Shea TM, Kothadia KJ, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104:15-21
3. Yeh TF, Lin YJ, Hsieh WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics. 1997;100(4). Available at: www.pediatrics.org/cgi/content/full/100/4/e3
4. Stark AR, Carlo W, Tyson JE, et al. Adverse effects of early dexamethasone in extremely low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001;344:95-101
5. O'Shea TM, Kothadia KJ, Klinepeter KL, Goldstein DJ, Jackson B, Dillard RG. Follow-up of preterm infants treated with dexamethasone for chronic lung disease. Am J Dis Child. 1993;147:658-661
6. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101(5). Available at: www.pediatrics.org/cgi/content/full/101/5/e7
7. Halliday H. Clinical trials of postnatal corticosteroids: inhaled and systemic. Biol Neonate. 1999;76:29-40
8. Halliday HL, Ehrenkranz RA. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;(1):CD001146
9. Halliday HL, Ehrenkrantz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cohchrane Database Syst Rev. 2003;(1):CD001144
10. Halliday HL, Ehrenkrantz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cohchrane Database Syst Rev. 2003;(1):CD001145
11. American Academy of Pediatrics, Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330-338
12. Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Paediatr Child Health. 2002;7:20-28
13. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair J. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: Effect modification by risk for chronic lung disease. Pediatrics. 2005;115:655-661
14. Shinwell ES, Karplus M, Recih D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Chld Fetal Neonatal Ed. 2000;83:F177-F181
15. Shinwell ES, Karplus M, Bader D, et al. Neonatologists are using much less dexamethasone. Arch Dis Chld Fetal Neonatal Ed. 2003;88:F432-F433
16. Carboneau C. Using diffusion of innovations and academic detailing to spread evidence-based practices. J Healthc Qual. 2005;27:48-52